Less than a year after raising seed funding from Milwaukee venture capital firm Gateway Capital Partners and relocating from Madison to Milwaukee, health data technology startup Geno.Me (pronounced “genome”) is ready to go to market.
Geno.Me is a data exchange platform that connects researchers with anonymized health data and pays consumers who opt to share their own medical and genomic records from sites like Ancestry.com and 23andMe. The company has raised a total of $400,000 (U.S.) in funding over 1 round. This was a Seed round raised on Nov 11, 2021.
It is a data exchange platform that links a person’s genetic report with their electronic health records.
The company’s platform connects electronic health record data with genomic information from services like 23andMe, MyChart and Anscestry.com in hopes of furthering medical research. Individuals who share their data with the platform are compensated on a monthly basis, while the business promises them total privacy and anonymity.
These linked datasets are encrypted and sold to companies conducting precision health research and developing pharmaceuticals.
Geno.Me was founded by Britt Gottschalk, a management consultant who has worked in health care, insurance and business communications.
The company was just launched and there isn’t much information about it available online. You can see the limited information that has already been published at https://www.yourgeno.me/. However, I suspect we all will hear more about Geno.Me before long.